465 related articles for article (PubMed ID: 30277207)
1. Case Report:
De Souza JN; Soares BNRR; Goes LL; Lima CS; Barreto NMPV; Jacobina BS; Gonçalves N; Teixeira MCA; Galvão-Castro B; Grassi MFR; Soares NM
Am J Trop Med Hyg; 2018 Dec; 99(6):1583-1586. PubMed ID: 30277207
[No Abstract] [Full Text] [Related]
2. Normal serum IgE levels and eosinophil counts exhibited during Strongyloides stercoralis infection.
Higashiarakawa M; Hirata T; Tanaka T; Parrott G; Kinjo T; Naka H; Hokama A; Fujita J
Parasitol Int; 2017 Feb; 66(1):807-812. PubMed ID: 27744050
[TBL] [Abstract][Full Text] [Related]
3. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
Ashida C; Kinoshita K; Nozaki Y; Funauchi M
BMC Infect Dis; 2020 Jul; 20(1):470. PubMed ID: 32615937
[TBL] [Abstract][Full Text] [Related]
4. [Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
Richter J; Schwarz U; Duwe S; Ellerbrok H; Poggensee G; Pauli G
Dtsch Med Wochenschr; 2005 Apr; 130(16):1007-10. PubMed ID: 15830313
[TBL] [Abstract][Full Text] [Related]
5. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.
Salles F; Bacellar A; Amorim M; Orge G; Sundberg M; Lima M; Santos S; Porto A; Carvalho E
Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):526-9. PubMed ID: 23843560
[TBL] [Abstract][Full Text] [Related]
6. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
[TBL] [Abstract][Full Text] [Related]
7. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
Carvalho EM; Da Fonseca Porto A
Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
[TBL] [Abstract][Full Text] [Related]
8. Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
Satoh M; Toma H; Sato Y; Takara M; Shiroma Y; Kiyuna S; Hirayama K
Clin Exp Immunol; 2002 Feb; 127(2):354-9. PubMed ID: 11876761
[TBL] [Abstract][Full Text] [Related]
9. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan.
Hayashi J; Kishihara Y; Yoshimura E; Furusyo N; Yamaji K; Kawakami Y; Murakami H; Kashiwagi S
Am J Trop Med Hyg; 1997 Jan; 56(1):71-5. PubMed ID: 9063365
[TBL] [Abstract][Full Text] [Related]
10. Strongyloides stercoralis larvae or egg: Which came first?
Poloni JAT; Zanotelli ML; Pedroso AS; Trein MR; Tasca T
Transpl Infect Dis; 2019 Dec; 21(6):e13177. PubMed ID: 31541527
[TBL] [Abstract][Full Text] [Related]
11. Utility of PCR in Patients with
Blaizot R; Simon S; Brottier J; Blanchet D; Brousse P; Boukhari R; Demar M
Am J Trop Med Hyg; 2019 Oct; 101(4):848-850. PubMed ID: 31436152
[No Abstract] [Full Text] [Related]
12. Association between Strongyloides stercoralis infection and cortisol secretion in alcoholic patients.
Silva ML; Inês Ede J; Souza AB; Dias VM; Guimarães CM; Menezes ER; Barbosa LG; Alves Mdel C; Teixeira MC; Soares NM
Acta Trop; 2016 Feb; 154():133-8. PubMed ID: 26592319
[TBL] [Abstract][Full Text] [Related]
13. Strongyloides stercoralis and HTLV-1 coinfection in CD34+ cord blood stem cell humanized mice: Alteration of cytokine responses and enhancement of larval growth.
Springer LE; Patton JB; Zhan T; Rabson AB; Lin HC; Manser T; Lok JB; Hess JA; Abraham D
PLoS Negl Trop Dis; 2021 Jul; 15(7):e0009559. PubMed ID: 34314415
[TBL] [Abstract][Full Text] [Related]
14. Diagnosis of Strongyloides stercoralis in a peritoneal effusion from an HIV-seropositive man. A case report.
Hong IS; Zaidi SY; McEvoy P; Neafie RC
Acta Cytol; 2004; 48(2):211-4. PubMed ID: 15085754
[TBL] [Abstract][Full Text] [Related]
15. A case of Strongyloides stercoralis infection.
Hong SJ; Han JH
Korean J Parasitol; 1999 Jun; 37(2):117-20. PubMed ID: 10388270
[TBL] [Abstract][Full Text] [Related]
16. [Clinical and immunological consequences of the association between HTLV-1 and strongyloidiasis].
Porto MA; Muniz A; Oliveira Júnior J; Carvalho EM
Rev Soc Bras Med Trop; 2002; 35(6):641-9. PubMed ID: 12612748
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cell expansion in HTLV-1 and strongyloidiasis co-infection is associated with reduced IL-5 responses to Strongyloides stercoralis antigen.
Montes M; Sanchez C; Verdonck K; Lake JE; Gonzalez E; Lopez G; Terashima A; Nolan T; Lewis DE; Gotuzzo E; White AC
PLoS Negl Trop Dis; 2009 Jun; 3(6):e456. PubMed ID: 19513105
[TBL] [Abstract][Full Text] [Related]
18. HTLV-1 decreases Th2 type of immune response in patients with strongyloidiasis.
Porto AF; Neva FA; Bittencourt H; Lisboa W; Thompson R; Alcântara L; Carvalho EM
Parasite Immunol; 2001 Sep; 23(9):503-7. PubMed ID: 11589779
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Strongyloides stercoralis infection in patients with HTLV-1.
Pereira Vieira Barreto NM; Brito Farias MM; Oliveira CL; Almeida Costa Araujo W; Rios Grassi MF; Nascimento de Souza J; Soares Jacobina B; Aquino Teixeira MC; Galvão-Castro B; Matos Soares N
Biomedica; 2022 Mar; 42(1):31-40. PubMed ID: 35471168
[TBL] [Abstract][Full Text] [Related]
20. Influence of parasite load on the diagnosis and occurrence of eosinophilia in alcoholic patients infected with Strongyloides stercoralis.
Silva MLS; Inês EJ; Souza JN; Souza ABS; Dias VMS; Oliveira LN; Guimarães CM; Menezes ER; Barbosa LG; Alves MCM; Teixeira MCA; Soares NM
J Helminthol; 2019 Jan; 93(1):21-25. PubMed ID: 29179791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
